Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)

Status:
Not yet recruiting

Trial end date:
2024-11-18

Target enrollment:

Participant gender:

This trial will the efficacy of KM-819 compared to placebo in subjects with MSA for slowing the progression of MSA.

Phase 2

Kainos Medicine Inc.

Parexel